Craif’s miSignal Test Aims to Make Cancer Detection Easier, Faster, and Cheaper
Craif raises $22M to expand its AI-powered, urine-based early cancer detection tool, miSignal, into the U.S. market, aiming for simpler screenings.
HealthTech Innovation